report on 2 patients, one female and one male transsexual; in both, Type III stress urinary incontinence developed after gender reassignment surgery. Both patients were treated by periurethral injection of gluteraldehyde cross-linked collagen resulting in a marked symptomatic improvement in association with a significant rise in abdominal leak point pressures. We believe these are the first reported cases of collagen injection being used for urinary incontinence after gender reassignment surgery.
The reported prevalence of transsexualism varies between 1:25,000 and l:lOO,OOO with a reported male:female ratio of between 5:l and 20: 1. lw3 Considerable controversy exists regarding the indications for gender reassignment surgery as well as the various surgical techniques used. For patients undergoing this type of surgery, specific postoperative complications include graft infection, fistula formation, urethral and neovaginal stenosis, impotence, and continuing psychosexual dysfunction. 4-7 Although urethral and vesical fistulas appear to be the most common cause of urinary incontinence, the urethral sphincteric mechanism also may be disrupted as a result of surgery.
Twenty years ago, polytef was introduced for the treatment of stress urinary incontinence.8,9 Subsequent long-term follow-up has lead to concern of particle migration and long-term results.lO-l2 Periurethral collagen has been used successfully for the treatment of patients with intrinsic sphincter dysfunction without associated morbity.13
Collagen, a glutaraldehyde cross-linked bovinederived material has been the subject of a multicenter study 14-18 Briefly, the material produces a significant increase in the ability of the urethra to withstand abdominal pressure as an expulsive force.19,20 In a three-year follow-up period, 80 percent of patients who became continent after colla- We report on 2 transsexual patients, one female and one male; in both severe stress incontinence developed after gender reassignment surgery. Both patients were treated by periurethral injection of gluteraldehyde cross-linked collagen resulting in marked symptomatic improvement in association with a significant rise in abdominal leak point pressures. We believe these are the first reported cases of collagen injection being used for urinary incontinence after gender reassignment surgery CASE REPORTS
CASE I
A thirty-five-year-old female transsexual with severe stress urinary incontinence was referred to the University of Michigan Medical Center. The patient had undergone gender reassignment surgery over three years previously. This included a colpohysterectomy, adnexectomy, bilateral mastectomy, phalloplasty (using a rectus abdominis muscle graft), and urethra transposition.
Numerous postoperative complications developed including recurrent urethrocutaneous fistulas, urethral diverticula, urethral calculi, meatal stenosis, and severe stress urinary incontinence.
Further reconstructive procedures were performed including a gracilis myocutaneous graft to the site of recurrent fistula formation, perineal urethroplasty, and bladder neck needle suspension. The patient remained incontinent, voiding urine through the site of the original urethral meatus. Fluorourodynamic evaluation revealed severe Type III stress urinary incontinence
with a widely open bladder neck and an abdominal leak point pressure of 28 cm water (Fig. 1) . Over the following eighteen months, this patient underwent cystoscopic transurethral collagen injection on four occasions. A total of 70 cc of collagen was used. Ten months after the last treatment, her leak point pressure is in excess of 128 cm water. She enjoys a significant symptomatic improvement, only wearing a pad during jogging for minimal stress urinary incontinence. 0s~ 2 A thirty-seven-year-old male transsexual presented with stress urinary incontinence, having undergone gender reassignment surgery more than three years previously This included bilateral breast augmentation, bilateral orchiectomy, penectomy, urethral transposition, and vaginoplasty using invaginated penoscrotal flaps. Postoperative complications included graft infection, vaginal stenosis, and urinary incontinence.
The patient was maintained on continuous oral estrogen. Fluorourodynamic evaluation revealed Type III stress urinary incontinence with a leak point pressure of 87 cm water (Fig. 2) . Digital rectal examination Abdominal leak point pressure of 87 cm water in male transsexual after gender reassignment surgery.
revealed an atrophic prostate gland. This patient subsequently underwent cystoscopic transurethral collagen injection on two occasions. A total of 25 cc of collagen were used. Seven months after the last treatment, this patient complains only of mild urge urinary incontinence.
Repeat fluorourodynamic assessment reveals a leak point pressure of 126 cm water.
COMMENT
Direct urethral sphincter injury and denervation are the probable causes of Type III stress urinary incontinence in both patients reported.
In the male transsexual patient, estrogen-induced prostate atrophy may be an additional factor contributing to incontinence.
Surgical correction of Type III stress urinary incontinence requires either sling suspension of the bladder neck or artificial sphincter insertion. 24.25 Anatomic distortion and tissue fibrosis in these cases would render these procedures both technically difficult and potentially hazardous.
Injectable collagen has been available since 1983 and was initially used in plastic surgery.26 Studies revealed that the majority of collagen was reabsorbed in ninety days.27 Since that time, collagen has been cross-linked with gluteraldehyde which in human studies seems to provide a matrix for the ingrowth of host collagen providing a more permanent urethral coaptation.'R,28
The results of multicenter trials suggest that glutaraldehyde cross-linked collagen maintains a urethral continence effect against abdominal pressure for periods up to two years after injection.'7~1*~20~21 The effect is objectively measured by determining the amount of abdominal pressure required to induce urinary leakage prior to and following collagen injection. That measurement is the most valid method to assess the strength of the urethral sphincter vis a vis abdominal pressure. Collagen injection provided a significantly lower risk therapeutic option for the patients described in this report. Both tolerated the procedure well and were satisfied with the outcome. Although the indications and techniques of gender reassignment surgery remain subjects of controversy, periurethral collagen injection appears to have a role in the treatment of urinary incontinence arising after such surgery.
